PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-gamma-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26492476 ↗2015Reported benefit

Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-gamma-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.

MouseWounddb/db type 2 diabetic mice with m/m littermate controlsMalen = n=10 per groupLocal injection at the incision site

Model: Surgical skin incision (postincisional pain model) in type 2 diabetic db/db mice, with outcomes followed for 7 days after incision

Rosiglitazone plus resolvin D1 alleviated mechanical hyperalgesia in db/db mice whereas rosiglitazone alone did not (day 4: 0.506 plus or minus 0.106 versus 0.068 plus or minus 0.12; day 7: 0.529 plus or minus 0.184 versus 0.153 plus or minus 0.183). The combination markedly reduced local neutrophi…

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.